Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer
A more than 2-fold increased risk of prostate cancer was seen for patients whose first melanoma diagnosis was 10 to 15 years before study recruitment.
Skin Cancer
QOL Up With Pembrolizumab vs Ipilimumab, HDI in Resected Melanoma
Adjuvant pembrolizumab improved quality of life when compared with ipilimumab or high-dose interferon α 2b.
Lack of Consensus Regarding Follow-Up After Keratinocyte Carcinoma Treatment
A systematic review of clinical practice guidelines revealed substantial variation in recommendations for follow-up after initial treatment for keratinocyte carcinoma.
Subset of Stage I Melanoma Patients Have Very Low Mortality Rate
Researchers identified a subset of melanoma patients with stage I lesions and negative clinical nodes who had a very low risk of death.
Relatlimab-Nivolumab Combo Deemed Promising in Resectable Melanoma
Relatlimab plus nivolumab yields a high pathologic complete response rate in resectable stage III or oligometastatic stage IV melanoma, a phase 2 study suggests.
Breast Implant-Associated Cancers: What Providers and Patients Need to Know
Patients with breast implants are at risk of developing squamous cell carcinoma and various types of lymphoma in the capsules around the implants.
USPSTF: Evidence Still Lacking for Routine Skin Cancer Screening
Current evidence is insufficient for assessing the balance of benefits and harms of screening for asymptomatic teens and adults.
Poor Outcomes Seen in Advanced Cancer Patients Treated With Inpatient ICI Therapy
Inpatient treatment with immune checkpoint inhibitors is associated with poor survival outcomes in patients with advanced cancer.
Researchers Identify Optimal Sequence of Treatment for BRAF-Mutant Melanoma
The optimal sequence of treatment for BRAF-mutant melanoma is nivolumab-ipilimumab followed by dabrafenib-trametinib, a study suggests.
American Indians, Alaska Natives Engage in Few Skin Cancer Prevention Behaviors
Researchers at Brigham and Women’s Hospital investigated the skin cancer prevention behaviors of these rarely studied ethnic groups.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...